1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carter, RL; Frye, JL; Johnston, TP; Kussner, CL; Lomax, NR; Narayanan, VL; Plowman, J | 1 |
Benjamin, RS; Bodey, GP; Burgess, MA; Feldman, LD; Feun, LG; Papadopoulos, N; Plager, C; Savaraj, N; Yap, BS | 1 |
Earhart, RH; Golomb, FM; Muggia, FM | 1 |
3 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Melanoma
Article | Year |
---|---|
Studies on synthesis and anticancer activity of selected N-(2-fluoroethyl)-N-nitrosoureas.
Topics: Animals; Antineoplastic Agents; Ethane; Hydrocarbons, Fluorinated; Melanoma; Mice; Nitrosourea Compounds | 1984 |
A phase II trial of PCNU in patients with malignant melanoma and central nervous system metastases.
Topics: Brain Neoplasms; Drug Evaluation; Humans; Injections, Intravenous; Leukopenia; Melanoma; Nitrosourea Compounds; Skin Neoplasms; Thrombocytopenia | 1985 |
Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Time Factors | 1985 |